Trial Profile
Effects of Aliskiren on Blood Pressure, Heart and Kidney in Elderly Hypertensive Chronic Kidney Disease Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Hypertension; Kidney disorders
- Focus Biomarker; Pharmacodynamics
- 01 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Nov 2011 Planned End Date changed from 1 Dec 2012 to 1 May 2012 as reported by ClinicalTrials.gov.
- 27 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.